Megestrol acetate.
D000230:Adenocarcinoma / Q000628:therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000628:therapy; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004353:Drug Evaluation, Preclinical; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy; D007700:Kinetics; D008297:Male; D008535:Megestrol / Q000031:analogs & derivatives* / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity; D019290:Megestrol Acetate; D011471:Prostatic Neoplasms / Q000628:therapy; D014594:Uterine Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents; D008535:Megestrol; D019290:Megestrol Acetate